Glagov revisited: coronary artery disease phenotype on non-invasive imaging provides rationale for implementing preventive pharmacotherapy-a case report.
Pruthvi C RevaiahPatrick W J C SerruysDenise P YatesYoshinobu OnumaJose Luis ZamoranoPublished in: European heart journal. Case reports (2023)
Our case exemplifies the value of CCTA as a diagnostic 'one-stop shop' (CCTA, finite element analysis, computed tomographic density [CTD], tissue characterization analysis, FAI analysis, WSS and wall strain, and etc.) when stratifying a patient with non-obstructive CAD. With further development of novel potent anti-lipidaemic and anti-inflammatory drugs, non-obstructive lesions with adverse plaque and haemodynamic parameters will have the opportunity to be treated with additional preventive pharmacological therapy.
Keyphrases
- coronary artery disease
- anti inflammatory drugs
- high resolution
- clinical trial
- percutaneous coronary intervention
- finite element analysis
- case report
- stem cells
- type diabetes
- emergency department
- coronary artery bypass grafting
- mesenchymal stem cells
- cardiovascular events
- cardiovascular disease
- photodynamic therapy
- bone marrow
- acute coronary syndrome
- newly diagnosed
- replacement therapy